Inspicos
Sponsored
Sponsored
-
Sponsored by InspicosA case concerning a payment made after the nine-month opposition period because of a problem with the EPO’s online filing software offers a useful checklist, says Edward Farrington of Inspicos
-
Sponsored by InspicosWhile concrete definitions are still lacking, Peter Koefoed of Inspicos says patent applicants seeking protection for second medical uses of products could now find it easier to build their case
-
Sponsored by InspicosSzonja Szenczi-Molnár of Inspicos explains why patent applicants should clearly explain the alternatives and possible combinations concerning claims when drafting description text, in light of a ruling on the allowability of amendments
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos summarises revisions to the Rules of Procedure of the Boards of Appeal on the cut-off point for appeal case amendments, the issuance of preliminary opinions, and the announcement of decisions
-
Sponsored by InspicosEdward Farrington of Inspicos suggests what measures can be taken to ensure the requirements of patent application assignments are fulfilled after a ‘text string’ signature was declared invalid
-
Sponsored by InspicosEdward Farrington of Inspicos reports that guidance is being sought from the EPO Enlarged Board of Appeal three decades after a decision on the analysis of complex products
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos says that clarification from the EPO Enlarged Board of Appeal may be necessary after a series of rulings concerning the format of oral proceedings in appeals
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos explains a ruling on the acceptance of evidence that is made public after the filing of an application to prove a technical effect
-
Sponsored by InspicosThe European patent system will undergo wholesale reform in June 2023. Jakob Pade Frederiksen of Inspicos explains what the changes mean for proprietors and applicants
-
Sponsored by InspicosThe European Patent Office (EPO)’s requirement for the description of a patent to confirm the claims at the final stage of grant or opposition proceedings is coming under attack, as Jakob Pade Frederiksen of Inspicos explains
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos P/S discusses the Unitary Patent and Unified Patent Court regime expected to enter into force by early 2023
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos P/S discusses a technical board of appeal referral that deals with the issue of entitlement to priority
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos P/S explains the EBA’s G 1/21 decision
-
Sponsored by InspicosPeter Koefoed of Inspicos P/S explains the findings of a recent decision concerning the inventiveness of computer-implemented simulation methods
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos P/S assesses the legitimacy of the EPO’s adaptation of video conferencing solutions in proceedings
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos P/S explains the findings of a recent decision by the EPO Board of Appeal, which permits the introduction of new facts and evidence in proceedings
-
Sponsored by InspicosUnder the exceptional circumstances caused by the COVID-19 pandemic, the EPO has postponed all oral proceedings in opposition scheduled for the rest of the year. Only oral proceedings already scheduled to take place by videoconference or to be held by videoconference with the parties' consent will take place this year. Oral proceedings in examination are still being held by videoconference whilst oral proceedings in appeal in principle still take place as scheduled.
-
Sponsored by InspicosThe Enlarged Board of Appeal of the EPO (EBA) has recently issued opinion G 3/19, which concludes that plants and animals exclusively obtained by “essentially biological processes” are exempt from patentability. This finding only affects patents derived from patent applications filed after July 1 2017.